How a Mid-Size CDMO Generated 3x More Qualified Leads with Pipeline Signal Intelligence
Transparency note: This case study documents the pipeline methodology and a representative engagement scenario. Figures are directional and anonymized; exact client results are shared under NDA on request.
A mid-size CDMO needed a way to identify prospects early.
The Solution
BioVance deployed the CI Platform to shift from reactive lead generation to proactive pipeline building using interconnected data sources.
1. Clinical Trial Signal Monitoring
2. Patent and IP Activity Tracking
3. Funding and Investment Signals
4. Regulatory Submission Monitoring
How Graph-Based Lead Intelligence Works
The Results
Within eight months, the results were clear:
More Qualified Leads
From 18 to 54 monthly.
Shorter Sales Cycle
Sales cycle cut 60%.
New Contracts Attributed
$5M in new contracts.
Higher Win Rate
Win rate rose to 55%.
"Before Contextual Intelligence, our business development team spent their time chasing the same leads as every other CDMO in the market. The platform changed the game entirely. We now see companies forming months before they start evaluating manufacturing partners. We engage them with context, not cold calls, and our win rate on those deals is more than double what we achieve through traditional channels. The $5 million in new contracts from signal-based leads paid for the platform many times over in the first year alone."
Transform Your Lead Generation
See how CI Platform's signal intelligence can help your team identify high-value prospects before your competitors do.
Try the Demo